Harmony Biosciences (HRMY) Competitors $32.68 -0.11 (-0.34%) (As of 10:31 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HRMY vs. XNCR, TARO, AIMT, RARX, OPK, ASND, LEGN, ELAN, LNTH, and BPMCShould you be buying Harmony Biosciences stock or one of its competitors? The main competitors of Harmony Biosciences include Xencor (XNCR), Taro Pharmaceutical Industries (TARO), Aimmune Therapeutics (AIMT), Ra Pharmaceuticals (RARX), OPKO Health (OPK), Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), Elanco Animal Health (ELAN), Lantheus (LNTH), and Blueprint Medicines (BPMC). These companies are all part of the "medical" sector. Harmony Biosciences vs. Xencor Taro Pharmaceutical Industries Aimmune Therapeutics Ra Pharmaceuticals OPKO Health Ascendis Pharma A/S Legend Biotech Elanco Animal Health Lantheus Blueprint Medicines Harmony Biosciences (NASDAQ:HRMY) and Xencor (NASDAQ:XNCR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation, dividends and community ranking. Is HRMY or XNCR more profitable? Harmony Biosciences has a net margin of 17.98% compared to Xencor's net margin of -232.77%. Harmony Biosciences' return on equity of 23.16% beat Xencor's return on equity.Company Net Margins Return on Equity Return on Assets Harmony Biosciences17.98% 23.16% 14.24% Xencor -232.77%-30.92%-21.74% Which has more volatility and risk, HRMY or XNCR? Harmony Biosciences has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Xencor has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500. Do analysts recommend HRMY or XNCR? Harmony Biosciences currently has a consensus price target of $47.00, indicating a potential upside of 43.82%. Xencor has a consensus price target of $35.75, indicating a potential upside of 50.91%. Given Xencor's stronger consensus rating and higher possible upside, analysts clearly believe Xencor is more favorable than Harmony Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Harmony Biosciences 2 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.56Xencor 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor HRMY or XNCR? Xencor received 451 more outperform votes than Harmony Biosciences when rated by MarketBeat users. Likewise, 73.36% of users gave Xencor an outperform vote while only 66.25% of users gave Harmony Biosciences an outperform vote. CompanyUnderperformOutperformHarmony BiosciencesOutperform Votes5366.25% Underperform Votes2733.75% XencorOutperform Votes50473.36% Underperform Votes18326.64% Do insiders and institutionals hold more shares of HRMY or XNCR? 86.2% of Harmony Biosciences shares are held by institutional investors. 30.8% of Harmony Biosciences shares are held by company insiders. Comparatively, 5.2% of Xencor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher valuation & earnings, HRMY or XNCR? Harmony Biosciences has higher revenue and earnings than Xencor. Xencor is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHarmony Biosciences$582.02M3.20$128.85M$2.1115.49Xencor$168.34M9.85-$126.09M-$3.20-7.40 Does the media favor HRMY or XNCR? In the previous week, Harmony Biosciences and Harmony Biosciences both had 4 articles in the media. Harmony Biosciences' average media sentiment score of 0.57 beat Xencor's score of 0.41 indicating that Harmony Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Harmony Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Xencor 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryHarmony Biosciences beats Xencor on 12 of the 18 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HRMY vs. The Competition Export to ExcelMetricHarmony BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.86B$6.48B$5.07B$8.80BDividend YieldN/A8.11%4.99%4.07%P/E Ratio15.494.9789.5613.60Price / Sales3.20371.451,224.8087.40Price / Cash12.4552.5939.4536.27Price / Book3.1210.306.976.33Net Income$128.85M$153.61M$119.04M$225.93M7 Day Performance-0.97%-1.73%-1.78%-0.96%1 Month Performance-6.49%-7.26%-3.59%1.06%1 Year Performance18.97%31.10%31.64%26.59% Harmony Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HRMYHarmony Biosciences4.7919 of 5 stars$32.68-0.3%$47.00+43.8%+18.1%$1.86B$582.02M15.49200XNCRXencor3.5491 of 5 stars$23.69-0.1%$35.75+50.9%+19.3%$1.66B$168.34M-7.41280TAROTaro Pharmaceutical IndustriesN/A$42.97flat$43.00+0.1%N/A$1.62B$629.18M29.841,554Analyst ForecastNegative NewsAIMTAimmune TherapeuticsN/A$34.49flatN/AN/A$2.26BN/A-8.69228RARXRa PharmaceuticalsN/A$47.99flatN/A+0.0%$2.27B$3M-20.7772OPKOPKO Health4.4597 of 5 stars$1.58-0.3%$2.75+74.6%+6.8%$1.07B$863.50M0.003,930ASNDAscendis Pharma A/S3.0066 of 5 stars$122.93-1.2%$191.77+56.0%+32.7%$7.45B$288.08M0.00640Analyst UpgradeLEGNLegend Biotech1.7671 of 5 stars$39.91-0.6%$81.46+104.1%-33.7%$7.28B$285.14M0.001,800Analyst RevisionELANElanco Animal Health4.1237 of 5 stars$13.47+0.2%$17.14+27.3%+13.1%$6.66B$4.42B33.609,300LNTHLantheus4.5969 of 5 stars$87.85+1.6%$122.50+39.4%+25.1%$6.11B$1.30B14.38834Positive NewsBPMCBlueprint Medicines2.713 of 5 stars$94.03-0.8%$122.11+29.9%+43.9%$5.97B$249.38M0.00640Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies Xencor Alternatives Taro Pharmaceutical Industries Alternatives Aimmune Therapeutics Alternatives Ra Pharmaceuticals Alternatives OPKO Health Alternatives Ascendis Pharma A/S Alternatives Legend Biotech Alternatives Elanco Animal Health Alternatives Lantheus Alternatives Blueprint Medicines Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HRMY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
